Clearmind Medicine (CMND) Competitors $1.03 +0.01 (+0.93%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$1.04 +0.01 (+1.17%) As of 09/5/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. SYBX, EDSA, LSB, CYCC, NERV, HOTH, BLRX, CMMB, LPCN, and MRKRShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include Synlogic (SYBX), Edesa Biotech (EDSA), LakeShore Biopharma (LSB), Cyclacel Pharmaceuticals (CYCC), Minerva Neurosciences (NERV), Hoth Therapeutics (HOTH), BioLineRx (BLRX), Chemomab Therapeutics (CMMB), Lipocine (LPCN), and Marker Therapeutics (MRKR). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Its Competitors Synlogic Edesa Biotech LakeShore Biopharma Cyclacel Pharmaceuticals Minerva Neurosciences Hoth Therapeutics BioLineRx Chemomab Therapeutics Lipocine Marker Therapeutics Clearmind Medicine (NASDAQ:CMND) and Synlogic (NASDAQ:SYBX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations. Does the media refer more to CMND or SYBX? In the previous week, Clearmind Medicine's average media sentiment score of 0.00 equaled Synlogic'saverage media sentiment score. Company Overall Sentiment Clearmind Medicine Neutral Synlogic Neutral Which has more risk and volatility, CMND or SYBX? Clearmind Medicine has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Synlogic has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Which has better valuation and earnings, CMND or SYBX? Synlogic is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearmind MedicineN/AN/A-$5.26M-$1.10-0.94SynlogicN/AN/A-$23.36M-$0.08-18.25 Do insiders and institutionals believe in CMND or SYBX? 96.1% of Clearmind Medicine shares are held by institutional investors. Comparatively, 63.4% of Synlogic shares are held by institutional investors. 3.0% of Synlogic shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is CMND or SYBX more profitable? Synlogic's return on equity of -8.09% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Clearmind MedicineN/A -164.79% -71.12% Synlogic N/A -8.09%-5.50% SummaryClearmind Medicine and Synlogic tied by winning 4 of the 8 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.35M$2.84B$5.79B$9.92BDividend YieldN/A50.34%6.71%4.52%P/E Ratio-0.9423.3476.1526.13Price / SalesN/A571.71463.3081.99Price / CashN/A167.8736.9659.04Price / Book1.415.5011.486.09Net Income-$5.26M$32.95M$3.29B$266.51M7 Day Performance-2.37%2.88%1.27%0.46%1 Month Performance7.27%8.63%7.94%4.59%1 Year Performance-19.53%1.88%62.94%26.04% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine0.4423 of 5 stars$1.03+0.9%N/A-20.2%$4.35MN/A-0.94N/ASYBXSynlogicN/A$1.46-1.4%N/A-0.5%$17.31M$10K-18.2580Positive NewsEDSAEdesa Biotech1.2708 of 5 stars$2.44+0.6%$5.00+105.3%-42.7%$17.03MN/A-1.8420Gap UpLSBLakeShore Biopharma1.4754 of 5 stars$0.81-0.9%N/A-81.0%$17.03M$85.67M0.00773Positive NewsShort Interest ↓Gap DownCYCCCyclacel Pharmaceuticals1.2675 of 5 stars$7.49-0.8%N/A-97.2%$16.90M$10K-0.0114Positive NewsAnalyst DowngradeShort Interest ↓NERVMinerva Neurosciences3.4557 of 5 stars$2.35-1.7%$5.00+112.8%-9.3%$16.71MN/A1.599HOTHHoth Therapeutics2.5022 of 5 stars$1.23-1.6%$4.00+225.2%+5.6%$16.57MN/A-1.154BLRXBioLineRx2.263 of 5 stars$3.61-6.2%$26.00+620.2%-85.1%$16.41M$17.25M-0.4140High Trading VolumeCMMBChemomab Therapeutics3.4369 of 5 stars$3.40-2.3%$8.50+150.0%-66.3%$16.40MN/A-5.7620News CoverageShort Interest ↓LPCNLipocine3.2753 of 5 stars$3.08+1.8%$9.00+192.7%-22.7%$16.37M$11.20M-3.5310News CoverageMRKRMarker Therapeutics4.2073 of 5 stars$1.00-20.6%$13.17+1,216.7%-71.3%$16.30M$6.59M-0.7360Positive NewsShort Interest ↓High Trading Volume Related Companies and Tools Related Companies SYBX Competitors EDSA Competitors LSB Competitors CYCC Competitors NERV Competitors HOTH Competitors BLRX Competitors CMMB Competitors LPCN Competitors MRKR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
